Close Menu

WHO

Xpert Ebola joins three other tests on the World Health Organization's list of in vitro diagnostics eligible for procurement in Ebola-affected countries.

The World Health Organization calls for the public release of clinical trial results within a year of the completion of data collection.

Sensitivity of GeneXpert MTB/RIF was better than microscopy, but low enough compared to culture to conclude that a negative Xpert result does not rule out TB in children.

Cepheid is now considering adapting TB tests in development to cover the mutations, an executive told GenomeWeb.

Tests in development for the Alere q include HIV, tuberculosis, and Ebola assays, and it will initially be targeted to low-resource settings in the developing world.

NEW YORK (GenomeWeb) — ATCC has partnered with the US Centers for Disease Control and Prevention and Thermo Fisher Scientific's Life Technologies, among other organizations, to manufacture and distribute a rapid, cost-effective genotyping kit to monitor HIV-1 drug resistance in resource-limited c

Global non-profit health advocacy organization Unitaid said today that its board has approved $30 million in funding to increase access to Cepheid's Xpert MTB/RIF diagnostic test for multi-drug-resistant tuberculosis in resource-poor areas of the world.

Thermo Fisher Scientific said this week it has acquired the exclusive rights from diagnostics firm Nephromics to use placental growth factor protein as a biomarker for the diagnosis of preeclampsia and eclampsia.

Researchers used the PacBio system to sequence the O104;H4 strain of Escherichia coli responsible for a recent outbreak in Europe that resulted in thousands of illnesses and more than 50 deaths.

Pages

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.